---
title: "Drug Discovery Advancement Consultancy"
ocid: "ocds-h6vhtk-079209"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-079209"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-079209.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-079209.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "University Of Edinburgh"
published: "2026-10-28"
---

# Drug Discovery Advancement Consultancy

Buyer: University Of Edinburgh  
Current stage: Award  
OCID: ocds-h6vhtk-079209

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-079209)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-079209.json)

## Summary

The University of Edinburgh’s Baillie Gifford Pandemic Sciences Hub procured specialised strategic consultancy to advance drug discovery and development. The work includes scientific, medical and commercial advice, alongside support for creating spinout companies and commercialising research. It is intended to help the Hub deliver its project requirements, including work involving therapeutic innovation, integration of artificial intelligence, strategic collaborations and mobilisation of resources. This is research and development consultancy (CPV 73000000). The delivery location is Edinburgh. The requirement combines drug discovery and development expertise with commercialisation and spinout support, rather than being a general management consultancy assignment.

The procurement is complete and the contract was awarded to Future Bio Consulting Ltd. The University used a limited procedure without publishing a prior competition, on the stated ground that competition was absent for technical reasons: the selected consultant was considered to have a distinctive combination of scientific, medical and commercial skills and project-specific knowledge. The contract was signed on 26 October 2026 and is valued at £286,440. Its initial period is 42 months, with one optional six-month extension, giving a maximum duration of 48 months. The requirement was handled as a single lot. The stated basis for selection was the consultant’s combined expertise and knowledge needed to meet the Hub’s project requirements.

For suppliers considering comparable future work from the University of Edinburgh’s pandemic sciences programme, credibility would depend on bringing together drug discovery and development expertise with scientific, medical and commercial judgement. The selected requirement also points to experience in therapeutic innovation, applying artificial intelligence in this context, building strategic collaborations and mobilising resources. Commercialisation capability matters alongside the research advisory work: suppliers should be able to support the creation and development of spinout businesses and help translate discoveries into commercial activity. The buyer cited this combination of specialist skills and project-specific understanding as the reason for appointing its chosen consultant without competition. A supplier strong in only one element may therefore be less well placed than a team able to connect technical drug-development advice with commercial strategy and project delivery.

## Notice

This University of Edinburgh requires highly specialised drug discovery and development consultancy including spinout and commercialisation support.

### Lot Information

Lot 1

The Baillie Gifford Pandemic Sciences Hub intend to appoint Future Bio Consultancy to provide highly specialised strategic advisory services in drug discovery and development including associated spinout and commercialisation support. The University considers competition to be absent for technical reasons as per Public Contracts (Scotland) Regulations 2015-33 (1) (b) (ii)Technical Reasons: The consultant identified possesses unique scientific, medical, commercial skills and project-specific knowledge (including therapeutic innovation, AI integration, strategic collaborations, and resource mobilisation) that are all required collectively to enable the University to meet its project requirements.

### Procurement Information

The Baillie Gifford Pandemic Sciences Hub intend to appoint Future Bio Consultancy to provide highly specialised strategic advisory services in drug discovery and development including associated spinout and commercialisation support. The University considers competition to be absent for technical reasons as per Public Contracts (Scotland) Regulations 2015-33 (1) (b) (ii)Technical Reasons: The consultant identified possesses unique scientific, medical, commercial skills and project-specific knowledge (including therapeutic innovation, AI integration, strategic collaborations, and resource mobilisation) that are all required collectively to enable the University to meet its project requirements.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/101898-2026 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 28 Oct 2026 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | Not specified |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £286,440 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | University Of Edinburgh |
| Locality | EDINBURGH |
| Postcode area | Edinburgh |
| Postcode | EH1 1HT |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | City Centre |
| Westminster constituency | Edinburgh East and Musselburgh |
| Delivery location | TLM75 City of Edinburgh |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | Future Bio Consulting Ltd |

## CPV Codes

### Divisions

- 73 - Research and development services and related consultancy services

### Codes

- 73000000 - Research and development services and related consultancy services

## Release History

- 28 Oct 2026 at 10:22 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/101898-2026

## Notice URLs

- http://www.ed.ac.uk
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000846686
- https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=846686
- https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA00107

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-079209. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-079209.json.
